Chandra Asri Pacific Valuation
Is PTPI.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Por debajo del valor justo
Muy por debajo del valor justo
Price-To-Sales vs. similares
Price-To-Sales vs. Industria
PM vs. Ratio Justo
Pronóstico de los analistas
Share Price vs Fair Value
What is the Fair Price of PTPI.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Por debajo del valor justo: PTPI.F ($0.3) cotiza por encima de nuestra estimación de valor razonable ($0.27)
Muy por debajo del valor justo: PTPI.F cotiza por encima de nuestra estimación del valor razonable.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PTPI.F?
Other financial metrics that can be useful for relative valuation.
| What is PTPI.F's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$38.74b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 17.9x |
| Enterprise Value/EBITDA | 473.2x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does PTPI.F's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.1x | ||
DOW Dow | 0.9x | 3.7% | US$42.0b |
LYB LyondellBasell Industries | 0.8x | -4.8% | US$34.0b |
WLK Westlake | 1.6x | 3.1% | US$20.6b |
OLN Olin | 1x | 4.3% | US$7.0b |
PTPI.F Chandra Asri Pacific | 17.9x | 2.1% | US$614.2t |
Price-To-Sales vs. similares: PTPI.F es caro según su Ratio Price-To-Sales (12.6x) en comparación con la media de sus homólogos (0.9x).
Price to Earnings Ratio vs Industry
How does PTPI.F's PE Ratio compare vs other companies in the US Chemicals Industry?
Price-To-Sales vs. Industria: PTPI.F es caro en función de su Ratio Price-To-Sales (12.6x) en comparación con la media del sector US Chemicals (1.2x).
Price to Sales Ratio vs Fair Ratio
What is PTPI.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 17.9x |
| Fair PS Ratio | n/a |
PM vs. Ratio Justo: Datos insuficientes para calcular PTPI.F's Price-To-Sales Fair Ratio para el análisis de valoración.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$0.41 | US$0.12 -71.6% | 33.2% | US$0.15 | US$0.077 | n/a | 2 |
| Apr ’25 | n/a | US$0.096 0% | 13.8% | US$0.11 | US$0.078 | n/a | 3 |
| Mar ’25 | n/a | US$0.096 0% | 13.8% | US$0.11 | US$0.078 | n/a | 3 |
| Feb ’25 | n/a | US$0.096 0% | 13.8% | US$0.11 | US$0.078 | n/a | 3 |
| Jan ’25 | n/a | US$0.096 0% | 13.8% | US$0.11 | US$0.078 | n/a | 3 |
| Dec ’24 | US$0.18 | US$0.096 -47.1% | 13.8% | US$0.11 | US$0.078 | n/a | 3 |
| Nov ’24 | n/a | US$0.11 0% | 1.5% | US$0.11 | US$0.11 | n/a | 2 |
| Oct ’24 | n/a | US$0.11 0% | 1.5% | US$0.11 | US$0.11 | n/a | 2 |
| Sep ’24 | n/a | US$0.14 0% | 24.1% | US$0.18 | US$0.11 | n/a | 2 |
| Aug ’24 | n/a | US$0.14 0% | 24.1% | US$0.18 | US$0.11 | n/a | 2 |
| Jul ’24 | US$0.14 | US$0.14 +1.7% | 24.1% | US$0.18 | US$0.11 | n/a | 2 |
| Jun ’24 | n/a | US$0.14 0% | 24.1% | US$0.18 | US$0.11 | n/a | 2 |
| May ’24 | US$0.15 | US$0.14 -8.5% | 24.1% | US$0.18 | US$0.11 | n/a | 2 |
| Apr ’24 | US$0.15 | US$0.14 -6.9% | 24.1% | US$0.18 | US$0.11 | n/a | 2 |
| Mar ’24 | n/a | US$0.16 0% | 23.6% | US$0.19 | US$0.10 | n/a | 3 |
| Feb ’24 | US$0.15 | US$0.16 +0.6% | 23.6% | US$0.19 | US$0.10 | n/a | 3 |
| Jan ’24 | n/a | US$0.16 0% | 23.6% | US$0.19 | US$0.10 | n/a | 3 |
| Dec ’23 | n/a | US$0.16 0% | 23.6% | US$0.19 | US$0.10 | US$0.18 | 3 |
| Nov ’23 | US$0.12 | US$0.15 +27.8% | 23.9% | US$0.19 | US$0.11 | n/a | 4 |
| Oct ’23 | US$0.14 | US$0.16 +14.9% | 21.0% | US$0.20 | US$0.13 | n/a | 4 |
| Sep ’23 | n/a | US$0.16 0% | 21.0% | US$0.20 | US$0.13 | n/a | 4 |
| Aug ’23 | n/a | US$0.17 0% | 18.1% | US$0.20 | US$0.13 | n/a | 3 |
| Jul ’23 | US$0.61 | US$0.16 -74.3% | 14.6% | US$0.19 | US$0.13 | US$0.14 | 4 |
| Jun ’23 | n/a | US$0.16 0% | 14.6% | US$0.19 | US$0.13 | n/a | 4 |
| May ’23 | n/a | US$0.16 0% | 14.6% | US$0.19 | US$0.13 | US$0.15 | 4 |
| Apr ’23 | n/a | US$0.15 0% | 10.4% | US$0.17 | US$0.14 | US$0.15 | 4 |
Pronóstico de los analistas: El precio objetivo es inferior al precio actual de la acción.